Context Therapeutics, Inc. (CNTX)
0.1935
+0.01
(+2.98%)
USD |
NASDAQ |
Nov 06, 16:00
0.1942
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics Cash from Investing (Quarterly) : -4.518M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.518M |
| March 31, 2026 | -0.0373M |
| December 31, 2025 | -2.00M |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | -0.0339M |
| December 31, 2024 | 0.00 |
| September 30, 2024 | -14.76M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.50M |
| June 30, 2022 | -0.0018M |
| March 31, 2022 | -0.035M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.25M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| EyePoint, Inc. | 75.10M |
| Neumora Therapeutics, Inc. | 0.00 |
| LENZ Therapeutics, Inc. | 28.66M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -131.99M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.020M |
| Free Cash Flow | -40.53M |
| Free Cash Flow Per Share (Quarterly) | -0.1212 |
| Free Cash Flow to Equity (Quarterly) | -11.50M |
| Free Cash Flow to Firm (Quarterly) | -11.54M |
| Free Cash Flow Yield | -222.0% |